Filing Details

Accession Number:
0000886163-13-000112
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-20 18:49:57
Reporting Period:
2013-11-18
Filing Date:
2013-11-20
Accepted Time:
2013-11-20 18:49:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1342894 P John Sharp 11119 North Torrey Pines Road, Suite 200
La Jolla CA 92037
Vp Finance And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-18 624 $9.96 24,790 No 4 M Direct
Common Stock Disposition 2013-11-18 1,123 $53.00 23,667 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-11-18 624 $0.00 624 $9.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,542 2020-02-15 No 4 M Direct
Footnotes
  1. Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/15/10.